MedinCell S.A. (EPA:MEDCL)

MedinCell Cash Flow Statement

Financials in millions EUR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	-18.44	-25.04	-32.01	-24.81	-18.99
Depreciation & Amortization	1.38	1.52	1.5	1.36	1.14
Other Amortization	0.61	0.2	0.17	0.16	0.2
Loss (Gain) From Sale of Assets	0.16	0.3	0.03	-0	-
Stock-Based Compensation	2.96	2.81	2.28	2.39	1.56
Other Operating Activities	8.26	5.11	10.06	1.9	3.33
Change in Accounts Receivable	-0.89	-0.16	-1.29	0.08	-0.26
Change in Accounts Payable	2.15	-2.33	1.2	0.03	-0.18
Change in Other Net Operating Assets	23.28	5.67	-2.94	-2.48	1.07
Operating Cash Flow	19.47	-11.92	-21.01	-21.36	-12.13
Capital Expenditures	-0.75	-0.32	-0.58	-1.62	-0.65
Sale of Property, Plant & Equipment	-	0	0.05	0.02	-
Sale (Purchase) of Intangibles	-0.91	-0.87	-0.45	-0.35	-0.17
Investment in Securities	-12.95	0.02	2.23	1.55	-0.28
Other Investing Activities	1.4	0.55	0.04	0.1	0.04
Investing Cash Flow	-13.21	-0.61	1.3	-0.32	-1.06
Long-Term Debt Issued	-	13.84	29.98	3.31	18.71
Long-Term Debt Repaid	-4.81	-9.46	-24.77	-2.84	-9.57
Net Debt Issued (Repaid)	-4.81	4.38	5.21	0.47	9.14
Issuance of Common Stock	43.29	25.47	0.81	0.05	42.29
Repurchase of Common Stock	-	-0.03	-	-0.19	-
Other Financing Activities	-5.15	-4.29	-4.46	-1.13	-3.5
Financing Cash Flow	33.32	25.53	1.56	-0.8	47.92
Miscellaneous Cash Flow Adjustments	0	-	0	-	-0
Net Cash Flow	39.58	12.99	-18.15	-22.48	34.72
Free Cash Flow	18.72	-12.25	-21.58	-22.99	-12.78
Free Cash Flow Margin	67.51%	-102.52%	-158.04%	-275.67%	-156.11%
Free Cash Flow Per Share	0.63	-0.43	-0.86	-0.93	-0.58
Cash Interest Paid	1.7	2.15	4.46	1.13	3.5
Cash Income Tax Paid	0.16	0.09	-	-	-
Levered Free Cash Flow	4.74	-10.6	-16.5	-15.27	-7.88
Unlevered Free Cash Flow	7.92	-7.72	-14.04	-14.12	-5.64
Change in Working Capital	24.53	3.18	-3.04	-2.37	0.62

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.